Saudi Arabia’s Ministry of Investment signed an agreement with GSK on Monday to boost the Kingdom’s healthcare and life sciences sector, it revealed on Twitter.
For the latest headlines, follow our Google News channel online or via the app.
A new Memorandum of Understanding (MoU) signed by the two parties aims to localize manufacturing, transfer knowledge and technology, and set up research collaborations with the Kingdom’s healthcare experts, the ministry said.
Read more:
Saudi Arabia sees slight increase with 4,838 new COVID-19 cases
Saudi Arabia’s Crown Prince meets Russian special envoy for Syrian settlement
Lucid to build Saudi Arabia electric vehicle factory by 2026: Chairman
